170 related articles for article (PubMed ID: 35447408)
1. Exploration of naphthoquinone analogs in targeting the TCF-DNA interaction to inhibit the Wnt/β-catenin signaling pathway.
Morris A; Hoyle R; Pagare PP; Uz Zaman S; Ma Z; Li J; Zhang Y
Bioorg Chem; 2022 Jul; 124():105812. PubMed ID: 35447408
[TBL] [Abstract][Full Text] [Related]
2. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
3. The leukemia-associated Mllt10/Af10-Dot1l are Tcf4/β-catenin coactivators essential for intestinal homeostasis.
Mahmoudi T; Boj SF; Hatzis P; Li VS; Taouatas N; Vries RG; Teunissen H; Begthel H; Korving J; Mohammed S; Heck AJ; Clevers H
PLoS Biol; 2010 Nov; 8(11):e1000539. PubMed ID: 21103407
[TBL] [Abstract][Full Text] [Related]
4. CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling.
Zhang Y; Liu C; Duan X; Ren F; Li S; Jin Z; Wang Y; Feng Y; Liu Z; Chang Z
J Biol Chem; 2014 Aug; 289(33):22589-22599. PubMed ID: 24982424
[TBL] [Abstract][Full Text] [Related]
5. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive miR-145 co-repressed by TCF4-β-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer.
Wang W; Xiao X; Chen X; Huo Y; Xi WJ; Lin ZF; Zhang D; Li YF; Yang F; Wen WH; Yang AG; Wang T
Int J Cancer; 2018 Jan; 142(2):308-321. PubMed ID: 28921929
[TBL] [Abstract][Full Text] [Related]
7. KSHV vPK inhibits Wnt signaling via preventing interactions between β-catenin and TCF4.
Cha S; Kang MS; Seo T
Biochem Biophys Res Commun; 2018 Feb; 497(1):381-387. PubMed ID: 29432739
[TBL] [Abstract][Full Text] [Related]
8. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
Zhang Y; Toh L; Lau P; Wang X
J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964
[TBL] [Abstract][Full Text] [Related]
9. The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway.
Monin MB; Krause P; Stelling R; Bocuk D; Niebert S; Klemm F; Pukrop T; Koenig S
J Surg Res; 2016 Jun; 203(1):193-205. PubMed ID: 27338550
[TBL] [Abstract][Full Text] [Related]
10. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
11. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
[TBL] [Abstract][Full Text] [Related]
12. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
13. Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity.
Wang L; Deng K; Gong L; Zhou L; Sayed S; Li H; Sun Q; Su Z; Wang Z; Liu S; Zhu H; Song J; Lu D
Pharmacol Res; 2020 Sep; 159():104955. PubMed ID: 32485279
[TBL] [Abstract][Full Text] [Related]
14. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop.
Li T; Jian X; He H; Lai Q; Li X; Deng D; Liu T; Zhu J; Jiao H; Ye Y; Wang S; Yang M; Zheng L; Zhou W; Ding Y
J Exp Clin Cancer Res; 2018 Sep; 37(1):238. PubMed ID: 30253791
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
16. A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer.
Reabroi S; Chairoungdua A; Saeeng R; Kasemsuk T; Saengsawang W; Zhu W; Piyachaturawat P
Biomed Pharmacother; 2018 May; 101():414-421. PubMed ID: 29501763
[TBL] [Abstract][Full Text] [Related]
17. β-Catenin/TCF4 Complex-Mediated Induction of the
Aono S; Hatanaka A; Hatanaka A; Gao Y; Hippo Y; Taketo MM; Waku T; Kobayashi A
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31288376
[TBL] [Abstract][Full Text] [Related]
18. Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells.
Ju X; Ishikawa TO; Naka K; Ito K; Ito Y; Oshima M
Cancer Sci; 2014 Apr; 105(4):418-24. PubMed ID: 24447505
[TBL] [Abstract][Full Text] [Related]
19. Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists of β-catenin/TCF transcription.
Zeller J; Turbiak AJ; Powelson IA; Lee S; Sun D; Showalter HD; Fearon ER
Bioorg Med Chem Lett; 2013 Nov; 23(21):5814-20. PubMed ID: 24060489
[TBL] [Abstract][Full Text] [Related]
20. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
